| |
| |
|
| Insider
Information: |
Huang Jane |
| Relationship: |
|
| City: |
Camana Bay, Grand Cayman |
| State: |
E9 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
211,342 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$24,581,247 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
211,342 |
|
|
| Total
Value |
$24,581,247 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -163.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Beigene Ltd |
BGNE |
CMO, Hematology |
2021-12-14 |
160,055 |
2017-12-04 |
0 |
Premium* |
|
|
Prelude Therapeutics Inc |
PRLD |
|
2024-04-04 |
51,287 |
2023-04-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRLD |
Prelude Therapeutics Inc |
President, CMO |
• – – |
2024-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,375 |
54,634 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
President, CMO |
• – – |
2024-04-04 |
4 |
D |
$4.74 |
$15,865 |
D/D |
(3,347) |
51,287 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
President, CMO |
• – – |
2024-01-04 |
4 |
D |
$3.77 |
$14,492 |
D/D |
(3,844) |
45,259 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
President, CMO |
• – – |
2024-01-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,375 |
49,103 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
President, CMO |
• – – |
2023-10-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,375 |
39,728 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
President, CMO |
• – – |
2023-07-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,375 |
33,595 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
President, CMO |
• – – |
2023-07-04 |
4 |
D |
$4.65 |
$15,075 |
D/D |
(3,242) |
30,353 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
President, CMO |
• – – |
2023-04-06 |
4 |
S |
$6.12 |
$81,274 |
D/D |
(13,280) |
24,220 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
President, CMO |
• – – |
2023-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,500 |
37,500 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-12-14 |
4 |
AS |
$274.54 |
$417,211 |
D/D |
(1,500) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-12-14 |
4 |
OE |
$119.96 |
$179,940 |
D/D |
1,500 |
1,500 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-12-01 |
4 |
S |
$357.32 |
$377,493 |
D/D |
(1,049) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,049 |
1,049 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
14,820 |
160,055 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-11-17 |
4 |
OE |
$119.96 |
$179,940 |
D/D |
1,500 |
1,500 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-11-17 |
4 |
AS |
$376.16 |
$572,003 |
D/D |
(1,500) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-10-19 |
4 |
AS |
$362.05 |
$559,163 |
D/D |
(1,500) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-10-19 |
4 |
OE |
$119.96 |
$179,940 |
D/D |
1,500 |
1,500 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-09-20 |
4 |
AS |
$390.91 |
$2,387,774 |
D/D |
(6,000) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-09-20 |
4 |
OE |
$119.96 |
$719,760 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-09-13 |
4 |
AS |
$355.37 |
$4,620,390 |
D/D |
(12,901) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-09-02 |
4 |
S |
$327.18 |
$178,314 |
D/D |
(545) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
545 |
545 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-09-01 |
4 |
S |
$310.53 |
$168,307 |
D/D |
(542) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,124 |
312,948 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
